Imaging software developer Median Technologies and biopharmaceutical professional services firm inVentiv Health have formed a strategic alliance.
The companies will offer medical image analysis and management services for oncology clinical trials. Median's image interpretation and management services for oncology trials will complement inVentiv's oncology offerings, according to the vendors.
To maximize access to meaningful and appropriate imaging biomarkers, Median will offer its integrated imaging services -- including automated, standardized image management and end-point review -- to inVentiv clients performing early-stage studies. For late-stage studies, Median provides core technology that has been cleared by the U.S. Food and Drug Administration (FDA) and other regulatory bodies, according to the companies.
